Metabolic parameters and dry matter intake of ewes treated with butaphosphan and cyanocobalamin in the early postpartum period  by Pereira, Rubens Alves et al.
M
w
p
R
C
L
M
a
S
b
d
c
V
A
R
R
A
A
K
B
C
K
E
D
d
T
(
0
hSmall Ruminant Research 114 (2013) 140– 145
Contents lists available at SciVerse ScienceDirect
Small  Ruminant  Research
jou rna l h om epa ge: www.elsev ier .com/ locate /smal l rumres
etabolic  parameters  and  dry  matter  intake  of  ewes  treated
ith  butaphosphan  and  cyanocobalamin  in  the  early
ostpartum  period
ubens  Alves  Pereiraa,∗,  Samanta  Fensterseifera,  Vinícius  Boechel  Barcelosa,
harles  Ferreira  Martinsa,  Augusto  Schneidera, Eduardo  Schmitta,c,
uiz Francisco  Machado  Pfeifera,c, Francisco  Augusto  Burkert  Del  Pinoa,b,
arcio  Nunes  Corrêaa
Núcleo de Pesquisa, Ensino e Extensão em Pecuária (NUPEEC), Departamento de Clínicas Veterinária, Universidade Federal de Pelotas,
/N,  8A, CEP 96010-900 Pelotas, Rio Grande do Sul, Brazil1
Laboratótio de Bioquímica Clínica, Departamento de Bioquímica, Universidade Federal de Pelotas, CEP 96010-900 Pelotas, Rio Grande
o  Sul, Brazil
Centro de Pesquisa Agroﬂorestal de Rondônia – Embrapa CPAF, BR 364 – Km 5,5 – Zona Rural, Caixa Postal 127, CEP 76815-800 Porto
elho,  Rondônia, Brazil
a  r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 22 November 2012
eceived in revised form 15 May  2013
ccepted 29 May  2013
vailable online 25 June 2013
eywords:
utaphosphan
yanocobalamin
etone bodies
wes
ry matter intake
a  b  s  t  r  a  c  t
The  objective  of this  study  was  to  determine  the effects  of  butaphosphan  and  cyanocobal-
amin  injection  on  the  dry  matter  intake  and  metabolic  parameters  of  early  postpartum
ewes.  Eighteen  pregnant  ewes  (Texel  breed)  were  divided  into  two  experimental  groups,
at calving  day:  (1)  Treatment  Group  (BTC  Group;  n  =  9),  which  received  3  injections  of
butaphosphan  (1000  mg)  and  cyanocobalamin  (0.5 mg)  combination,  every  two  days  after
calving  (day  0–4  postpartum);  and  (2)  Control  Group  (CTL  Group;  n  =  9),  which  received
injections  of  saline  solution  (NaCl  0.9%)  in the  same  way  that  the  BTC Group.  Blood
samples  were  collected  once  a  day, from  day  1  to  day  7 postpartum  to  determine  con-
centrations  of  glucose,  non-esteriﬁed  fatty  acids  (NEFA),  acetone,  beta-hydroxybutyrate
(BHB),  calcium  (Ca) and  phosphorus  (P).  The  dry  matter  intake  was  higher  (P =  0.023)  in
the  BTC  group  (2.9  ±  0.2 vs.  2.0 ± 0.2  kg/day)  while  the  NEFA  concentration  in  this  group
was  lower  (0.47  ±  0.02 vs.  0.56  ± 0.02  mmol/L,  P = 0.006).  The  acetone  blood  concentration
decreased  on  the  BTC  group  (P = 0.068)  in  the  ﬁrst week  after  calving  (3.16  ±  0.34  mg/dL  and
4.05 ± 0.33  mg/dL  BTC  and  CTL  group,  respectively).  The  glucose  and  phosphorus  concen-
tration  of  the  BTC group  were  higher  (P = 0.027  and  P < 0.001,  respectively)  than  in the CTR
group. The  calcium  and BHB  concentrations  decreased  after  calving  in  all  ewes,  but  were
not different  between  groups.  In  conclusion,  butaphosphan  and  cyanocobalamin  injections
in the early  postpartum  period  in ewes  improved  the  energetic  status  and  had  an orexigenic
effect.
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1. Introduction
Physiological conditions of ketonemia are common in
ruminants and include nutritional deﬁciency, bovine keto-
sis and ovine pregnancy toxemia (Bruss, 1997). These
diseases are the result of the excessive lipid mobiliza-
tion due to the negative energy balance (NEB) and of
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the increased blood levels of non-esteriﬁed fatty acids
(NEFAs), which can be completely oxidized to CO2 and
H2O by Krebs cycle (KC), or partially oxidized to ketone
bodies (Caldeira, 2005; Zammit, 1990), as acetoacetate,
beta-hydroxybutyrate (BHB) and acetone (Church, 1993;
Drackley et al., 2001). The acetoacetate is unstable and
can be converted to acetone and carbon dioxide (Fukao
et al., 2004). The acetone by addition of H+, is trans-
formed into the intermediate isopropanol (Adler et al.,
1955), responsible for signals encephalopathy in cases of
high levels of ketone bodies during severe NEB (Pethick
et al., 1983). Therefore, the ketonemia is associated with
anorectic effects and decreased dry matter intake (DMI)
(Scharrer, 1999).
Strategies as the control of body condition (Sarginson,
2007) and the use of bovine somatotropin (Lucci et al.,
1998) have been used to minimize the NEB in ruminants.
Another alternative is the combination of butaphosphan
and cyanocobalamin used mainly to improve the immune
and energetic status in cows (Flasshoff, 1974; Larscheid,
1994; Simon, 1990). However, the exact mode of action of
these substances in combination is not yet fully known.
What is known is that cyanocobalamin is a cofactor of
the enzyme methylmalonyl-CoA mutase, which is essential
for entry of propionate into the KC and gluconeogene-
sis (Mcdowell, 2000). As a limited amount of glucose is
absorbed by intestine, soon after calving, when there is a
greater energy requirement, the animal becomes depend-
ent of the glucose from gluconeogenesis (Reynolds, 2006).
Furthermore, an insufﬁcient supply of cyanocobalamin,
especially after calving, might decrease the function of
methylmalonyl-CoA mutase and the cell energy synthe-
sis (Kennedy et al., 1990). The decrease of the KC activity
causes an accumulation of acetyl-CoA from the hepatic -
oxidation of NEFA, intensifying ketogenesis, and reducing
the DMI  (Baird, 1982). Butaphosphan, an organic source
of phosphorus, is important in cellular energy metabolism
and serves as substrate for the ADP/ATP cycle, synthe-
sis of creatine phosphate and nucleotides involved in
the hormonal action (cAMP, cGMP) (Cunningham, 2002).
Therefore, it can serve as a regulator of gluconeogene-
sis and glycolysis rates that depend on the availability
of phosphorus (Berg et al., 2006). Although cyanocobal-
amin and butaphosphan can directly interfere with certain
metabolic pathways, it is assumed that there is still an
indirect effect on hepatic metabolism, mainly in the pro-
cesses of -oxidation and ketogenesis, which could explain
the improvement in the energetic condition of the animals
treated with these substances (Furll et al., 2010; Rollin et al.,
2010). In addition, these substances can reduce the expres-
sion of ACSL1 mRNA (acyl-CoA synthetase), an enzyme
involved in -oxidation (Kreipe et al., 2011).
One of the main application ﬁelds of this metaphylactic
strategy is the treatment of ketosis in dairy cows (Rollin
et al., 2010), besides improving the energy synthesis dur-
ing the peripartum (Furll et al., 2010). Furthermore, other
beneﬁts to ruminants include the prevention of milk fever
(Schuh, 1994), the improvement of the productive and
reproductive performance (Flasshoff, 1974), the decreasing
of stress (Simon, 1990), and a faster recovery after surgical
procedures (Furll et al., 2006, 2010). In sheep, its use hassearch 114 (2013) 140– 145 141
been restricted to animals submitted to estrus synchro-
nization protocols in the search for a better reproductive
performance (Lopes et al., 2010).
The aim of this study was  to evaluate the effects of
a new metaphylactic strategy with butaphosphan and
cyanocobalamin on serum levels of NEFA, acetone, BHB
and the DMI  in postpartum ewes. Our hypothesis is that
the synergistic action of these substances improves the
gluconeogenesis, reduces the severity of NEB, plasma con-
centrations of acetone and BHB, increasing the DMI.
2. Material and methods
2.1. Animal welfare
All experimental procedures were approved by the Ethics Committee
on Animal Experimentation and are registered at Coordinating Council for
Education, Research and Extension of the Federal University of Pelotas, Rio
Grande do Sul, Brazil.
2.2. Animals and treatments
This study was  conducted in a farm located in southern Brazil
(31◦56′ S, 52◦14′ W),  with mean annual temperature of 16.3 ◦C and
average annual precipitation of 1.379 mm,  characteristics of a humid sub-
tropical climate. The experiment was realized from August to October
2010, under a thermal range from 10.7 to 21.8 ◦C, with eighteen pregnant
ewes of the Texel breed, from second or third calving of a single lamb. The
ewes were kept under the same management conditions, during pre and
post-partum (conﬁned in individual stalls). The animals were randomly
divided into two groups, immediately after calving: (1) Treatment Group
(BTC group, n = 9, BW mean of 54.68 ± 1.76 kg), that received 1000 mg
of  butaphosphan and 0.5 mg of cyanocobalamin (im, Catosal B12® , Bayer
Health Care, Sao Paulo, Brazil), (2) Control Group (CTL group, n = 9, BW
mean of 52.19 ± 1.84 kg), that received the same amount of physiological
solution (NaCl 0.9%). Three doses were administrated every 2 days after
calving.
2.3. Dry matter intake
The animals were subjected to a conﬁnement system, in individual
stalls, from calving to 7 days postpartum. During this period they were
fed ad libitum,  twice a day (at 7 a.m. and 7 p.m.) with a total mix, consist-
ing  of forage (corn silage) and concentrate (Table 1). The total mix  was
comprised of 60% of dry matter and 40% of concentrate. The total mix was
supplied 60% at morning (7 a.m.) and 40% at night (7 p.m.). The estimated
DMI  was  based on 3% of the BW.  Before each daily supply, the leftover
was  weighed, and daily DMI  estimated. The amount offered was adjusted
daily, so that the leftovers remained between 10% and 20% of the total
supply.
2.4. Collection of blood samples
Blood samples were daily collected, from ﬁrst to seventh postpartum
day, and placed into three tubes previously identiﬁed: tube 1, contain-
ing  KF (potassium ﬂuoride) glycolytic pathway inhibitor, for analysis of
glucose; tube 2, containing sodium ﬂuoride, for analysis of acetone; and
tube 3, without anticoagulant for the analysis of NEFA, BHB, Ca and P. The
second tube was  immediately frozen at −20 ◦C. The samples from tubes
1  and 3 were centrifuged at 3500 rpm for 15 min immediately after col-
lection. The plasma and serum were distributed at duplicate in previously
identiﬁed tubes and frozen at −20 ◦C.
2.5. Biochemical analysis
The concentrations of glucose, calcium (Ca) and phosphorus (P) were
analyzed by enzymatic colorimetric assay quantiﬁed by spectrophotome-
ter  (FEMTO 700 Plus, Femto Ind. e Com. de Instrumentos Ltda., São
Paulo, Brazil). The reagents were handled according to the manufacturer’s
instructions (Labtest® , Lagoa Santa, Brasil). Non-esteriﬁed fatty acid and
BHB were analyzed by a commercial kit (Wako NEFA-HR, Wako Chemicals
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Table 1
Composition and assurance levels of the concentrate used in the feed of the ewes (Ration Commercial Irgovino®).
Components Assurance levels
Minimum Maximum
Ground soybean hulls Unit – 120.00 g/kg
Ground  corn Crude protein 150.00 g/kg –
Defatted rice bran Mineral matter – 160.00 g/kg
Soybean meal Calcium 15.00 g/kg 19.00 g/kg
Wheat  meal Phosphorous 7.00 g/kg –
Mineral salt Fiber matter – 140.00 g/kg
Calcium carbonate ADF – 170.00 g/kg
Vitamin–mineral premix Ether extract 25 g/kg –
ADE  vitamin Sulphur 2.50 g/kg –
Vitamin A 3750.00U.i./kg –
Vitamin D3 1250.00U.i./kg –
Vitamin E 10.00U.i./kg –
Iodine 1.00 mg/kg –
Selenium 0.25 mg/kg –
Zinc 37.00 mg/kg –
Cobalt 0.50 mg/kg –
Iron  50.00 mg/kg –
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SA® , Richmond, EUA and Randox® , Randox Laboratories E.U.A.® , Ocean-
ide, CA, USA, respectively), according to (Ballou et al., 2009). Acetone was
nalyzed by gas chromatography (Sato and Shiogama, 2009). Coefﬁcients
f  variation were lower 10% for all assays.
.6. Statistical analysis
Data involving repeated measures over time (e.g., glucose, Ca, P, NEFA,
HB, acetone and DMI), considering the daily average of the animals in
ach  group, were analyzed by MIXED procedure of SAS® version 9.0 (SAS
nstitute Inc., Cary, NC, USA), to evaluate the main effects of treatment,
ime (days), and their interactions (Littell et al., 1998). When interactions
ere signiﬁcant (P < 0.05) a least square difference test was  used to detect
reatment effects at each time.
. ResultsThe dry matter intake of the BTC group (2.9 ± 0.2 kg/day)
as higher (P < 0.023) than CTL group (2.0 ± 0.2 kg/day,
able 2) during ﬁrst two days after calving (P = 0.002),
able 2
eekly average of metabolic parameters and dry matter intake (DMI) of ewes of
000  mg  of butaphosphan and 0.05 mg  of cyanocobalamin (BTC group, n = 09) dur
Parametersa Treatmentb
CTL group BTC group 
Ewes (n) 09 09
Glucose (mg/dL) 55.10 ± 1.93 61.26 ± 1.94 
NEFA  (mmol/L) 0.56 ± 0.02 0.47 ± 0.02 
BHB  (mmol/L) 0.41 ± 0.03 0.42 ± 0.03 
Acetone (mg/dL) 4.05 ± 0.33 3.16 ± 0.34 
Ca  (mg/dL) 9.71 ± 0.40 9.78 ± 0.39 
P  (mg/dL) 6.60 ± 0.16 7.4 ± 0.15 
DMI  (kg) 2.0 ± 0.20 2.90 ± 0.20 
BW  (kg) 52.19 ± 1.84 54.68 ± 1.76 
a Plasma concentration of glucose, non-esteriﬁed fatty acids (NEFA), beta-hyd
ntake  (DMI) and body weight (BW) of the ewes during ﬁrst week postpartum.
b Treatments consisted of three injections administered at days 0, 3 and 6 po
utaphosphan and 0.05 mg  of cyanocobalamin (n = 09).
c Analysis of repeated measures by mixed model procedure, evaluating the m
ere considered signiﬁcant when P < 0.05.2.50 g/kg –
according to Table 3. The BTC group had lower acetone con-
centration (P = 0.068) than CTR group (3.16 ± 0.34 mg/dL
and 4.05 ± 0.33 mg/dL, respectively) during ﬁrst week
after calving (Table 2). This reduction was  evident
from day 5 after calving, when acetone concentration
was  lower (P = 0.012) to BTC group, than CTR group
(Table 3). The glucose concentration to BTC group
was  higher (61.26 ± 1.94 mg/dL; P = 0.027), than to CTR
group (55.10 ± 1.93 mg/dL). The average of the phospho-
rus concentration was  higher (P < 0.001) to BTC group
(7.40 ± 0.15 mg/dL), than to CTR group (6.60 ± 0.16 mg/dL;
Table 2).
During the ﬁrst week after calving the average of NEFA
concentration to BTC group (0.47 ± 0.02 mmol/L) was  lower
(P = 0.006), than to CTR group (0.56 ± 0.02 mmol/L). The
body weight of the ewes from BTC group (54.68 ± 1.76 kg;
P = 0.025) was  higher, than CTR group (52.19 ± 1.84 kg). The
calcium and BHB concentrations decreased progressively
 the Texel breed that received injections of placebo (CTL group, n = 09) or
ing ﬁrst week postpartum.
Repeated measuresc
Treatment Period Treat.*period
0.027 0.144 0.738
0.006 0.229 0.830
0.751 <0.001 0.860
0.068 0.760 0.020
0.901 0.023 0.378
<0.001 <0.001 0.207
0.023 0.001 0.002
0.025 0.993 0.994
roxybutyrate (BHB), acetone, calcium (Ca), phosphorus (P), dry matter
stpartum. CTL Group = saline solution (n = 09); BTC Group = 1000 mg  of
ain effects of treatment, time (days), and their interactions. Interactions
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Table 3
Daily average of metabolic parameters and dry matter intake of Texel breed ewes, that received injections of placebo (CTL group, n = 09) or 1000 mg  of butaphosphan and 0.05 mg  of cyanocobalamin (BTC group,
n  = 09) during ﬁrst week postpartum.
Parametersa Treatmentb Period (days) Repeated measuresc
1 2 3 4 5 6 7 Treatment*period
Glucose (mg/dL) CTL Group 58.49 ± 5.03 60.64 ± 4.74 51.51 ± 4.74 55.72 ± 5.03 53.33 ± 5.02 54.26 ± 5.38 51.79 ± 5.81 0.738
BTC  Group 73.97 ± 5.38 59.41 ± 5.03 54.10 ± 5.38 66.70 ± 5.38 59.13 ± 5.38 60.08 ± 4.74 55.46 ± 4.74
NEFA  (mmol/L) CTL Group 0.67 ± 0.06 0.61 ± 0.06 0.54 ± 0.06 0.50 ± 0.06 0.53 ± 0.07 0.59 ± 0.06 0.51 ± 0.06 0.830
BTC  Group 0.55 ± 0.06 0.50 ± 0.06 0.51 ± 0.06 0.50 ± 0.06 0.43 ± 0.06 0.41 ± 0.06 0.40 ± 0.07
BHB  (mmol/L) CTL Group 0.63 ± 0.09 0.53 ± 0.11 0.16 ± 0.10 0.33 ± 0.09 0.47 ± 0.09 0.35 ± 0.10 0.41 ± 0.12 0.860
BTC  Group 0.69 ± 0.09 0.61 ± 0.10 0.28 ± 0.10 0.21 ± 0.09 0.41 ± 0.10 0.41 ± 0.09 0.40 ± 0.09
Acetone (mg/dL) CTL Group 2.40 ± 0.87 3.35 ± 0.87 4.29 ± 0.87 2.81 ± 0.87 5.26 ± 0.92a 5.57 ± 0.92a 4.69 ± 0.98a 0.020
BTC  Group 4.96 ± 0.98 2.66 ± 0.87 2.86 ± 0.92 4.02 ± 0.87 1.97 ± 0.92b 3.22 ± 0.92b 2.48 ± 0.87b
Ca (mg/dL) CTL Group 10.07 ± 0.84 9.87 ± 0.89 10.99 ± 0.96 10.56 ± 0.84 9.04 ± 0.84 8.47 ± 0.84 8.99 ± 0.84 0.378
BTC  Group 11.79 ± 0.79 9.45 ± 0.79 10.64 ± 1.05 8.92 ± 0.79 9.47 ± 0.84 8.00 ± 0.79 10.22 ± 0.79
P  (mg/dL) CTL Group 8.20 ± 0.44 6.24 ± 0.42 5.10 ± 0.42 6.36 ± 0.42 5.60 ± 0.44 7.19 ± 0.44 7.55 ± 0.47 0.207
BTC  Group 9.60 ± 0.42 6.83 ± 0.42 6.19 ± 0.42 6.83 ± 0.42 7.60 ± 0.44 7.06 ± 0.42 7.73 ± 0.42
DMI  (kg) CTL Group 1.11 ± 0.20a 1.03 ± 0.20a 2.50 ± 0.23 2.42 ± 0.20 2.48 ± 0.20 2.42 ± 0.21 2,69 ± 0.20 0.002
BTC  Group 2.87 ± 0.20b 2.87 ± 0.20b 2.95 ± 0.23 2.85 ± 0.20 2.83 ± 0.21 2.61 ± 0.21 2.95 ± 0.20
BW  (kg) CTL Group 52.50 ± 2.20 53.43 ± 2.35 51.38 ± 2.20 51.38 ± 2.20 52.08 ± 2.33 52.62 ± 2.20 51.96 ± 2.33 0.994
BTC  Group 53.57 ± 2.35 54.89 ± 2.07 54.56 ± 2.07 55.00 ± 2.07 54.63 ± 2.20 55.13 ± 2.20 55.00 ± 2.20
Different superscripts indicate differences at P < 0.05 between treatments in the speciﬁc period.
a Plasma concentration of glucose, non-esteriﬁed fatty acids (NEFA), beta-hydroxybutyrate (BHB), acetone, calcium (Ca), phosphorus (P), dry matter intake (DMI) and body weight (BW) of ewes during ﬁrst
week  postpartum.
b Treatments consisted of three injections administered at days 0, 3 and 6 postpartum. CTL Group = saline solution (n = 09); BTC Group = 1000 mg of butaphosphan and 0.05 mg  of cyanocobalamin (n = 09).
c Analysis of repeated measures by mixed model procedure, evaluating the main effects of the interactions between treatment and period (days). Interactions were considered signiﬁcant when P < 0.05.
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t days 1, 2 and 3 postpartum in all animals, but were not
ifferent between groups (Table 3).
. Discussion
In this study, the increase of the DMI  and decreased
cetone levels during ﬁrst week after calving in the ewes
reated with butaphosphan and cyanocobalamin, suggest
n improved energy status, mainly by increased of the DMI,
hich was associated with reduced lipid mobilization and
etogenesis. These results are similar to previous obser-
ations in dairy cows (Pereira et al., 2013; Rollin et al.,
010).
Besides the effect indirect of butaphosphan and
yanocobalamin into minimize NEB, we must consider
hat with the reduced levels of acetone, by the degra-
ation of its molecule, fragments of three (C3) and two
C2) carbons are produced and may  be incorporated in
etabolic pathways (Kalapos, 1999). When acetone blood
oncentration exceeds 4 mmol/L, intended to form acetate,
owever, if is below this level, it becomes part of the route
f transformation of ADP to ATP in the KC (Kosugi et al.,
986). In addition, the acetone is converted to methylgly-
xal by products of cytochrome P450IIE1 gene in the liver
Casazza et al., 1984). Two-way of C3 fragments have been
escribed, containing the common formation of pyruvate
s a ﬁnal product (Kalapos, 1999), which would have a
undamental role in the gluconeogenesis, as described in
odents and humans (Casazza et al., 1984; Kalapos et al.,
994).
Although acetone serves as a gluconeogenic substrate,
t also can interact with other substances that have an
ffect on glucose metabolism during hunger (Kalapos
t al., 1994). Thus, we  believe in the orexigenic effect
f the butaphosphan, increasing the DMI  mainly during
rst 2 days after calving. Besides, our results indicate
lucose levels increased (P = 0.027) in the treated ani-
als (Table 2), being consistent with the mechanism of
ction of cyanocobalamin, which acts as a cofactor for
ethylmalonyl-CoA mutase (an enzyme that catalyzes the
onversion of propionate to succinyl-CoA). This catalyza-
ion is key for the entry of fat acids in the KC to be
sed in gluconeogenesis (Kennedy et al., 1990). This action
avors the synthesis of energy, which can be increased
fter the 5th day postpartum, when the plasma acetone
s less than 4 mmol/L, integrating the route of transfor-
ation from ADP to ATP in the KC (Kosugi et al., 1986).
yanocobalamin is produced in the ruminant digestive
ystem, but soon after calving its blood levels are low
Girard and Matte, 1999). This occurs because the prepar-
um is the period of greatest fetal growth and the partition
f nutrients increases for the formation of colostrum
Duehlmeier et al., 2011; Schlumbohm and Harmeyer,
003). Thus, the functions of cyanocobalamin are com-
romised and its supplementation becomes a potential
lternative, which can, by the gluconeogenic action, sup-
ly the energy demanded from organism (Brozos et al.,
011).
Depending on the available energy, the body may
hoose the gluconeogenesis. But, the lipolysis mechanism
an simultaneously be used to provide energy to peripheralsearch 114 (2013) 140– 145
tissues (Kalapos et al., 1996). In addition, the hepatocytes
of animals with energy deﬁciency oxidize large quanti-
ties of fatty acids, increasing the rate of NADH/NAD in the
mitochondria (Enjalbert et al., 2001). However, as rumi-
nants, the hepatic conversion of acetoacetate to BHB and
then acetone requires only NAD and it does not depend on
the rate NADH/NAD mitochondrial, because its conversion
is cytosolic (Koundakjian and Snoswell, 1970), the forma-
tion of the ketone bodies typically occurs under presence
of glucogenic precursors.
The acetone blood concentration was  less in the BTC
group, from 4 days postpartum (Table 3), while on the
days before, the level was  increased (less than 4 mol/L)
what may  have contributed, together with butaphosphan
and cyanocobalamin, for increase the glycemia after day 4
(Kalapos et al., 1996). Furthermore, we must consider that,
gluconeogenic substrates may  provide NADPH and H+ to
cytochrome P450s, which acts in the metabolism of acetone
and reduces its blood levels, (Kalapos et al., 1994), corrob-
orating with our results mainly from day 4 postpartum.
In other studies (Furll et al., 2010; Krdzalic and
Curcic, 1976; Sarasola et al., 2008) realized with cows,
the signiﬁcant effects of combined butaphosphan and
cyanocobalamin on blood concentrations of phosphorus,
glucose and BHB were observed after treatment, but the
extent of the effect was even greater some days after. This
shows that some results are immediate and occur even dur-
ing the metabolism of substances, during its half-life, but
other physiological effects are only observed at medium
term. This maybe is related to lower severity of NEB of the
animals from this study, which gives them a faster recovery,
compared to the energy deﬁcit, impacting on variables such
as milk production, not evaluated in this study in sheep, but
proven in cows (Furll et al., 2010; Kreipe et al., 2011; Rollin
et al., 2010).
According to Table 2, the phosphorus blood concen-
tration of the BTC group was  higher (7.40 ± 0.15 mg/dL,
P < 0.001), than the CTL group (6.60 ±0.16 mg/dL, P < 0.001).
While Furll et al. (2010) found a similar result during a
study in dairy cows, Delport et al. (2006) and Rollin et al.
(2010) did not observed the same effect, because according
to them, the injection of butaphosphan not cause an imme-
diate increase of phosphorus in blood due to their organic
and stable form.
Therefore, we  can say that the metaphylactic strategy
with butaphosphan and cyanocobalamin during the recent
postpartum period of ewes, at dose used in this study
(2 mL/10 kg PV), plays a key role for decrease of NEB to the
reducing of the levels of ketone bodies and increase DMI,
corroborating with several previous studies realized with
dairy cows.
5. Conclusion
In conclusion, the treatment of ewes with the metaphy-
lactic combination of butaphosphan and cyanocobalamin
during ﬁrst week postpartum, decreases serum con-
centrations of NEFA and acetone, and increases blood
concentrations of P, glucose and dry matter intake, indi-
cating an overall improved energy status.
inant ReR.A. Pereira et al. / Small Rum
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